drugset / Trial / NCT06981234

Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

NCT06981234

RandomizedCrossoverDouble-blindTreatment

Summary

The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.

Timeline

Start
2024-08-14
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 250 mg